The Manufacturers Life Insurance Company Invests $170.89 Million in Synopsys, Inc. $SNPS

Key Points

• The Manufacturers Life Insurance Company acquired 383,089 Synopsys shares worth approximately $170.9 million, giving it a 0.20% stake. Institutional investors collectively own 85.47% of the company.
• Synopsys reported quarterly EPS of $3.35, exceeding estimates of $3.15, while revenue rose 41.9% year over year to $2.28 billion. The stock opened at $394.51, well below its 52-week high of $615.79.
• Analyst sentiment remains positive but mixed, with a consensus “Moderate Buy” rating and an average price target of $563.59. Meanwhile, the CEO and CFO sold shares under pre-arranged Rule 10b5-1 plans, with the CEO’s sale partly covering tax obligations.

The Manufacturers Life Insurance Company acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 383,089 shares of the semiconductor company's stock, valued at approximately $170,886,000. The Manufacturers Life Insurance Company owned 0.20% of Synopsys at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. Foronjy Financial LLC raised its holdings in Synopsys by 5.2% during the fourth quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company's stock valued at $210,000 after acquiring an additional 22 shares during the period. AGH Wealth Advisors LLC boosted its stake in shares of Synopsys by 4.4% in the first quarter. AGH Wealth Advisors LLC now owns 569 shares of the semiconductor company's stock worth $226,000 after acquiring an additional 24 shares during the period. Hardy Reed LLC boosted its stake in shares of Synopsys by 0.8% in the fourth quarter. Hardy Reed LLC now owns 3,309 shares of the semiconductor company's stock worth $1,554,000 after acquiring an additional 25 shares during the period. Annis Gardner Whiting Capital Advisors LLC grew its position in shares of Synopsys by 16.9% during the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 180 shares of the semiconductor company's stock worth $85,000 after purchasing an additional 26 shares in the last quarter. Finally, MCF Advisors LLC raised its stake in Synopsys by 17.8% during the 4th quarter. MCF Advisors LLC now owns 172 shares of the semiconductor company's stock valued at $81,000 after purchasing an additional 26 shares during the period. Institutional investors own 85.47% of the company's stock.

Synopsys Stock Performance

NASDAQ:SNPS opened at $394.51 on Tuesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. Synopsys, Inc. has a 1 year low of $366.00 and a 1 year high of $615.79. The stock's 50 day simple moving average is $418.53 and its two-hundred day simple moving average is $439.92. The company has a market cap of $75.54 billion, a price-to-earnings ratio of 91.32, a PEG ratio of 2.34 and a beta of 1.23.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business had revenue of $2.28 billion for the quarter, compared to analysts' expectations of $2.25 billion. During the same period in the prior year, the firm earned $3.67 EPS. The company's revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company's stock, valued at $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on SNPS shares. Weiss Ratings reissued a "hold (c-)" rating on shares of Synopsys in a report on Monday, June 8th. Wells Fargo & Company cut their price objective on shares of Synopsys from $535.00 to $450.00 and set an "equal weight" rating for the company in a report on Tuesday, August 11th. Robert W. Baird set a $558.00 price objective on shares of Synopsys in a research report on Thursday, May 28th. Morgan Stanley lowered their target price on shares of Synopsys from $525.00 to $500.00 and set an "equal weight" rating on the stock in a report on Wednesday, August 19th. Finally, Citigroup upped their target price on shares of Synopsys from $600.00 to $610.00 and gave the stock a "buy" rating in a research report on Thursday, May 28th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $563.59.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source